Anthony P Ford

Dr. Ford is co-founder and chief scientific officer of Afferent. An accomplished pharmacologist and former vice president of research at Roche, Dr. Ford initiated and drove the P2X3 program at Roche for over a decade. Dr. Ford brings more than 20 years of research and development experience at Roche and Syntex to Afferent, having led the progression of several novel drug candidates into early clinical development, focused particularly in the areas of pain and genitourinary therapeutics. Dr. Ford was trained in neuropharmacology and holds a Ph.D. from the University of Nottingham (UK).